drugset / Trial / NCT04251221
Measuring the Neuroimmune Response to Alcohol
Phase 0
Completed
14 enrolled
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
Non-randomizedSingle-groupOpen-labelBasic science
Summary
This study uses positron emission tomography imaging of the 18-kDa translocator protein to measure the brain's immune response to alcohol.
Timeline
- Start
- 2019-06-20
- Primary completion
- 2021-11-20
- Completion
- 2021-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alcohol | Other / unclassified | — | Oral |